What is the ticker symbol for Royalty Pharma plc?

The ticker symbol for Royalty Pharma plc is NASDAQ:RPRX

Does Royalty Pharma plc pay dividends?

Yes, Royalty Pharma plc pays dividends. The last payment was $0.24, with an ex-dividend date on August 14, 2026

What sector is Royalty Pharma plc in?

Royalty Pharma plc is in the Healthcare sector

What industry is Royalty Pharma plc in?

Royalty Pharma plc is in the Biotechnology industry

What country is Royalty Pharma plc based in?

Royalty Pharma plc is headquartered in United States

When did Royalty Pharma plc go public?

Royalty Pharma plc initial public offering (IPO) was on June 16, 2020

Is Royalty Pharma plc in the S&P 500?

No, Royalty Pharma plc is not included in the S&P 500 index

Is Royalty Pharma plc in the NASDAQ 100?

No, Royalty Pharma plc is not included in the NASDAQ 100 index

Is Royalty Pharma plc in the Dow Jones?

No, Royalty Pharma plc is not included in the Dow Jones index

When was Royalty Pharma plc last earnings report?

Royalty Pharma plc's most recent earnings report was on August 5, 2026

When does Royalty Pharma plc report earnings?

The next expected earnings date for Royalty Pharma plc is November 4, 2026

RPRX Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, RPRX price is $58.60, up +0.07% on August 14, 2026
Current Price All-Time High: RPRX price is currently -3.04% below its historical high of $60.44 set on July 29, 2026
Market Cap: RPRX current market cap is $34B, up +114.60% over the past 365 days
PE Ratio: RPRX current PE ratio is 31.20
Revenue: RPRX current annual revenue is $2.38B, up +5.06% year-over-year
Next Earnings: The next earnings release for RPRX is on November 4, 2026

Profile

Company profile for Royalty Pharma plc (RPRX)
Metric	Value
Full Name	Royalty Pharma plc
Ticker	NASDAQ: RPRX
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Jun 16, 2020
Indexes	Not included
Website	royaltypharma.com
Employees	100

Key Metrics

Royalty Pharma plc Key Details
Metric	Value	Date
Price	$58.60	Aug 14, 26
Price, 1D Change	+0.07%	Aug 14, 26
Market Cap	$34B	Aug 14, 26
TTM Dividend Yield	1.58%	Aug 14, 26
PE Ratio	31.20	Aug 14, 26
Beta	0.22	Aug 14, 26
Revenue	$2.38B	Dec 31, 25
Revenue, 1Y Change	+5.06%	Dec 31, 25
EPS	$1.78	Dec 31, 25
EPS, 1Y Change	-6.83%	Dec 31, 25

Events

Royalty Pharma plc Events
Metric	Value	Date
Next Earnings		Nov 4, 26
Last Qtr. Earnings		Aug 5, 26
Last Ann. Earnings		Feb 11, 26
Last Ex-Dividend	$0.24	Aug 14, 26
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

RPRX Estimates
Metric	Value	Date
EPS	$1.78	Dec 31, 25
EPS Estimate	$5.33	N/A
EPS Est. Change	+199.20%	N/A
Revenue	$2.38B	Dec 31, 25
Revenue Estimate	$3.50B	N/A
Revenue Est. Change	+47.03%	N/A
Current Price	$58.60	Aug 14, 26
Price Target	$64.00	-
Price Tgt. Change	+9.22%	-

🔒 Log In To Unlock Full Data

EPS

RPRX EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	$4.05	$1.91	-52.78%
2025	$4.64	$1.78	-61.59%
2026	$5.33	N/A	+199.20%
2027	$5.74	N/A	+222.04%

Revenue

RPRX revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$2.70B	$2.26B	-16.32%
2025	$3.21B	$2.38B	-25.99%
2026	$3.50B	N/A	+47.03%
2027	$3.81B	N/A	+60.19%

🔒 Log In To Unlock Full Data

Performance

RPRX Performance
Metric	Value	Date
Price, 1Y	+60.55%	Aug 14, 26
Price, 3Y	+94.62%	Aug 14, 26
Market Cap, 1Y	+114.60%	Aug 14, 26
Market Cap, 3Y	+149.71%	Aug 14, 26
Revenue, 1Y	+5.06%	Dec 31, 25
Revenue, 3Y	+6.30%	Dec 31, 25
EPS, 1Y	-6.83%	Dec 31, 25
EPS, 3Y	+1,721.47%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

RPRX Technical Indicators
Metric	Value	Date
Current Price	$58.60	Aug 14, 26
SMA 200	$47.50	Aug 14, 26
SMA 50	$56.82	Aug 14, 26
EMA 200	$48.97	Aug 14, 26
EMA 50	$56.60	Aug 14, 26
MACD	$0.40	Aug 14, 26
Beta	0.22	Aug 14, 26
ATR	$1.40	Aug 14, 26
14-Day RSI	55.00	Aug 14, 26
10-Day Volatility	22.77%	Aug 14, 26

Dividends

RPRX Dividends
Metric	Value	Date
Last Paid	$0.24	Aug 14, 26
Upcoming	N/A	N/A
Dividend Yield	1.50%	Aug 14, 26
Total Dividend	$0.88	Dec 31, 25
	$378.25M	Dec 31, 25
	28.56%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

RPRX Income & Profitability
Metric	Value	Date
Revenue	$2.38B	Dec 31, 25
EPS	$1.78	Dec 31, 25
Gross Profit	$2.37B	Dec 31, 25
Gross Margin	99.84%	Dec 31, 25
Operating Income	$1.56B	Dec 31, 25
Operating Margin	65.58%	Dec 31, 25
Net Income	$1.32B	Dec 31, 25
Net Margin	55.68%	Dec 31, 25
EBITDA	$1.56B	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

RPRX Financial Health
Metric	Value	Date
Debt To Equity	1.38	Dec 31, 25
	2.40	Dec 31, 25
	2.40	Dec 31, 25
	-	Dec 31, 25
	6	Jun 30, 26
	2.66	Aug 14, 26

Valuations

RPRX Valuations
Metric	Value	Date
PE Ratio	31.20	Aug 14, 26
	13.35	Aug 14, 26
	4.96	Aug 14, 26
	26.48	Aug 14, 26
	-	N/A

Balance Sheet

RPRX Balance Sheet
Metric	Value	Date
Book Value	$6.48B	Dec 31, 25
	$637.50M	Dec 31, 25
	$19.62B	Dec 31, 25
	$1.53B	Dec 31, 25
	$9.91B	Dec 31, 25
	$636.21M	Dec 31, 25
Total Debt	$8.97B	Dec 31, 25
	$380.00M	Dec 31, 25
	$19.40M	Dec 31, 25

Expenses

RPRX Expenses
Metric	Value	Date
	$1.61B	Dec 31, 25
	$814.82M	Dec 31, 25
	$3.85M	Dec 31, 25
	$0.00	Dec 31, 25
	$3.85M	Dec 31, 25
	$0.00	Dec 31, 25
	$0.00	Dec 31, 25

Cash Flow

RPRX Cash Flow
Metric	Value	Date
	$2.59B	Dec 31, 25
	-$1.71B	Dec 31, 25
	-$1.19B	Dec 31, 25
Capex	$1.70B	Dec 31, 25
	$897.24M	Dec 31, 25

Recent analyst updates

RPRX Recent analyst updates
Metric	Value	Date
JP Morgan	→	Aug 7, 26
TD Cowen	→	Jul 13, 26
JP Morgan	→	May 7, 26
Citigroup	→	May 7, 26
UBS	→	Apr 21, 26
Morgan Stanley	→	Apr 10, 26
UBS	→	Jan 30, 26
Citigroup	→	Jan 27, 26
TD Cowen	→	Dec 11, 25
Morgan Stanley	→	Oct 10, 25

Analyst sentiment

Institutional ownership

Screeners with RPRX

FAQ

What is the ticker symbol for Royalty Pharma plc?: The ticker symbol for Royalty Pharma plc is NASDAQ:RPRX
Does Royalty Pharma plc pay dividends?: Yes, Royalty Pharma plc pays dividends. The last payment was $0.24, with an ex-dividend date on August 14, 2026
What sector is Royalty Pharma plc in?: Royalty Pharma plc is in the Healthcare sector
What industry is Royalty Pharma plc in?: Royalty Pharma plc is in the Biotechnology industry
What country is Royalty Pharma plc based in?: Royalty Pharma plc is headquartered in United States
When did Royalty Pharma plc go public?: Royalty Pharma plc initial public offering (IPO) was on June 16, 2020
Is Royalty Pharma plc in the S&P 500?: No, Royalty Pharma plc is not included in the S&P 500 index
Is Royalty Pharma plc in the NASDAQ 100?: No, Royalty Pharma plc is not included in the NASDAQ 100 index
Is Royalty Pharma plc in the Dow Jones?: No, Royalty Pharma plc is not included in the Dow Jones index
When was Royalty Pharma plc last earnings report?: Royalty Pharma plc's most recent earnings report was on August 5, 2026
When does Royalty Pharma plc report earnings?: The next expected earnings date for Royalty Pharma plc is November 4, 2026

Data Sources & References

RPRX Official Website www.royaltypharma.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276826000003/0001802768-26-000003-index.htm
RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx